Anti-Vascular Endothelial Growth Factor (Anti-VEGF) therapy targets the protein VEGF, which plays a crucial role in the formation of new blood vessels (angiogenesis). This therapy is primarily used in the treatment of various ophthalmologic conditions, such as age-related macular degeneration (AMD), diabetic retinopathy, and retinal vein occlusion.
